Aryeh Jason
Director at LGND; Director at Aralez Pharmaceuticals Inc.; Director at VXRT
- Sold, on record
- $39.8M
- Dollars the filings state
- Form 4 sales
- 50
- Latest Jun 11, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- LGNDLIGAND PHARMACEUTICALS INCDirector
- Aralez Pharmaceuticals Inc.Director
- VXRTVaxart, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- VXRT1.1M shares
- Aralez Pharmaceuticals Inc.388,685 shares
- LGND259,644 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Aralez Pharmaceuticals Inc.UnusualMay 23, 2017 2017
Sold 388,685 shares at $1.44 ($558k)
Aryeh Jason, Director
Sold 100% of holdings ($558k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale LGNDPlan not statedAug 23, 2017 +92 days
Sold 2,000 shares at $127.99 ($256k)
Aryeh Jason, Director
Sold 1.7% of holdings ($14.9M position)114,651 shares left0.1x usual sizeFiling
- 3 Form 4 sale LGNDPlan not statedNov 17, 2017 +86 days
Sold 24,400 shares at $140.22 ($3.4M)
Aryeh Jason, Director
Sold 21.3% of holdings ($16.1M position)90,251 shares left1.3x usual sizeFiling
- 4 Form 4 sale LGNDPlan not statedFeb 23, 2018 +98 days
Sold 3,417 shares at $155.00 ($530k)
Aryeh Jason, Director
Sold 3.8% of holdings ($14M position)86,834 shares left0.2x usual sizeFiling
- 5 Form 4 sale LGNDPlan not statedMar 9, 2018 +14 days
Sold 7,500 shares at $175.73 ($1.3M)
Aryeh Jason, Director
Sold 8.6% of holdings ($15.3M position)79,334 shares left0.3x usual sizeFiling
- 6 Form 4 sale LGNDUnusualAug 17, 2018 +161 days
Sold 27,942 shares at $241.93 ($6.8M)
Aryeh Jason, Director
Sold 35.2% of holdings ($19.2M position)51,392 shares left2.2x usual sizeFiling
- 7 Form 4 sale LGNDNo planSep 23, 2025 +2594 days
Sold 10,000 shares at $170.81 ($1.7M)
Aryeh Jason, Director
No 10b5-1 planSold 12.6% of holdings ($13.5M position)69,289 shares leftFirst sale on recordFiling
- 8 Form 4 sale LGNDNo planJun 11, 2026 +261 days
Sold 5,000 shares at $250.00 ($1.3M)
Aryeh Jason, Director
No 10b5-1 planSold 4.6% of holdings ($26.9M position)102,580 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (50)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Jun 12, 2026 | LGND | Director | Form 4 sale | 5,000 | $1.3M | 4.6% | No plan | SEC |
| Sep 23, 2025 | Sep 24, 2025 | LGND | Director | Form 4 sale | 10,000 | $1.7M | 12.6% | No plan | SEC |
| Aug 17, 2018 | Aug 17, 2018 | LGND | Director | Form 4 sale | 27,942 | $6.8M | 35.2% | Unusual | SEC |
| Mar 9, 2018 | Mar 9, 2018 | LGND | Director | Form 4 sale | 7,500 | $1.3M | 8.6% | Plan not stated | SEC |
| Feb 23, 2018 | Feb 27, 2018 | LGND | Director | Form 4 sale | 3,417 | $530k | 3.8% | Plan not stated | SEC |
| Nov 17, 2017 | Nov 20, 2017 | LGND | Director | Form 4 sale | 24,400 | $3.4M | 21.3% | Plan not stated | SEC |
| Aug 23, 2017 | Aug 25, 2017 | LGND | Director | Form 4 sale | 2,000 | $256k | 1.7% | Plan not stated | SEC |
| May 23, 2017 | May 24, 2017 | Aralez Pharmaceuticals Inc. | Director | Form 4 sale | 388,685 | $558k | 100.0% | Unusual | SEC |
| May 12, 2017 | May 12, 2017 | LGND | Director | Form 4 sale | 37,247 | $4.1M | 24.2% | Unusual | SEC |
| Feb 28, 2017 | Feb 28, 2017 | LGND | Director | Form 4 sale | 32,000 | $3.4M | 17.2% | Unusual | SEC |
| Nov 25, 2016 | Nov 25, 2016 | LGND | Director | Form 4 sale | 18,479 | $2M | 9.0% | Plan not stated | SEC |
| Nov 18, 2016 | Nov 18, 2016 | LGND | Director | Form 4 sale | 6,330 | $666k | 3.0% | Plan not stated | SEC |
| May 6, 2016 | May 9, 2016 | LGND | Director | Form 4 sale | 25,000 | $3M | 10.6% | Unusual | SEC |
| Mar 8, 2016 | Mar 9, 2016 | LGND | Director | Form 4 sale | 6,129 | $620k | 2.5% | Plan not stated | SEC |
| Nov 11, 2015 | Nov 13, 2015 | LGND | Director | Form 4 sale | 3,000 | $304k | 1.2% | Plan not stated | SEC |
| Jun 4, 2015 | Jun 8, 2015 | LGND | Director | Form 4 sale | 1,640 | $152k | 0.7% | Plan not stated | SEC |
| May 20, 2015 | May 20, 2015 | LGND | Director | Form 4 sale | 9,240 | $807k | 3.6% | Plan not stated | SEC |
| Feb 14, 2014 | Feb 14, 2014 | LGND | Director | Form 4 sale | 40,320 | $3.1M | 14.1% | Plan not stated | SEC |
| Mar 15, 2011 | Mar 17, 2011 | VXRT | Director | Form 4 sale | 4,900 | $29k | 3.6% | Plan not stated | SEC |
| Mar 14, 2011 | Mar 16, 2011 | VXRT | Director | Form 4 sale | 3,400 | $20k | 2.4% | Plan not stated | SEC |
| Mar 11, 2011 | Mar 15, 2011 | VXRT | Director | Form 4 sale | 24,700 | $142k | 15.0% | Unusual | SEC |
| Dec 27, 2010 | Dec 29, 2010 | VXRT | Director | Form 4 sale | 15,093 | $87k | 100.0% | Unusual | SEC |
| Dec 15, 2010 | Dec 17, 2010 | VXRT | Director | Form 4 sale | 1,907 | $11k | 1.0% | Plan not stated | SEC |
| Dec 8, 2010 | Dec 10, 2010 | VXRT | Director | Form 4 sale | 4,705 | $26k | 2.5% | Plan not stated | SEC |
| Dec 1, 2010 | Dec 3, 2010 | VXRT | Director | Form 4 sale | 6,700 | $37k | 3.5% | Plan not stated | SEC |
| Nov 22, 2010 | Nov 22, 2010 | VXRT | Director | Form 4 sale | 8,195 | $43k | 4.1% | Plan not stated | SEC |
| Nov 11, 2010 | Nov 15, 2010 | VXRT | Director | Form 4 sale | 4,900 | $26k | 2.4% | Plan not stated | SEC |
| Nov 10, 2010 | Nov 12, 2010 | VXRT | Director | Form 4 sale | 17,600 | $94k | 7.9% | Plan not stated | SEC |
| Oct 20, 2010 | Oct 20, 2010 | VXRT | Director | Form 4 sale | 20,573 | $103k | 8.4% | Plan not stated | SEC |
| Oct 11, 2010 | Oct 13, 2010 | VXRT | Director | Form 4 sale | 4,422 | $22k | 1.8% | Plan not stated | SEC |
| Jun 11, 2010 | Aug 19, 2010 | VXRT | Director | Form 4 sale | 600 | $3k | 0.2% | Plan not stated | SEC |
| Jun 11, 2010 | Jun 15, 2010 | VXRT | Director | Form 4 sale | 2,147 | $12k | 0.9% | Plan not stated | SEC |
| Jun 3, 2010 | Jun 7, 2010 | VXRT | Director | Form 4 sale | 258 | $1k | 0.1% | Plan not stated | SEC |
| Mar 24, 2010 | Mar 26, 2010 | VXRT | Director | Form 4 sale | 65,027 | $406k | 20.5% | Unusual | SEC |
| Mar 22, 2010 | Mar 24, 2010 | VXRT | Director | Form 4 sale | 28,510 | $178k | 8.3% | Plan not stated | SEC |
| Mar 19, 2010 | Mar 23, 2010 | VXRT | Director | Form 4 sale | 7,800 | $47k | 2.2% | Plan not stated | SEC |
| Mar 18, 2010 | Mar 22, 2010 | VXRT | Director | Form 4 sale | 6,581 | $39k | 1.8% | Plan not stated | SEC |
| Mar 17, 2010 | Mar 19, 2010 | VXRT | Director | Form 4 sale | 11,419 | $68k | 3.1% | Plan not stated | SEC |
| Mar 15, 2010 | Mar 17, 2010 | VXRT | Director | Form 4 sale | 200 | $1k | 0.1% | Plan not stated | SEC |
| Mar 12, 2010 | Mar 16, 2010 | VXRT | Director | Form 4 sale | 16,600 | $98k | 4.3% | Plan not stated | SEC |
| Mar 11, 2010 | Mar 15, 2010 | VXRT | Director | Form 4 sale | 180,700 | $1.1M | 31.8% | Unusual | SEC |
| Mar 10, 2010 | Mar 12, 2010 | VXRT | Director | Form 4 sale | 16,100 | $92k | 2.8% | Plan not stated | SEC |
| Mar 8, 2010 | Mar 10, 2010 | VXRT | Director | Form 4 sale | 3,200 | $18k | 0.5% | Plan not stated | SEC |
| Jan 13, 2010 | Jan 15, 2010 | VXRT | Director | Form 4 sale | 13,800 | $76k | 2.3% | Plan not stated | SEC |
| Jan 12, 2010 | Jan 14, 2010 | VXRT | Director | Form 4 sale | 86,200 | $473k | 12.5% | Plan not stated | SEC |
| Jan 8, 2010 | Jan 8, 2010 | VXRT | Director | Form 4 sale | 91,965 | $484k | 11.8% | Plan not stated | SEC |
| Dec 22, 2009 | Dec 23, 2009 | VXRT | Director | Form 4 sale | 8,035 | $42k | 1.0% | Plan not stated | SEC |
| Dec 16, 2009 | Dec 18, 2009 | VXRT | Director | Form 4 sale | 4,045 | $21k | 0.5% | Plan not stated | SEC |
| Nov 17, 2009 | Nov 18, 2009 | VXRT | Director | Form 4 sale | 185,909 | $942k | 19.0% | Plan not stated | SEC |
| Nov 16, 2009 | Nov 18, 2009 | VXRT | Director | Form 4 sale | 255,276 | $1.2M | 20.7% | Plan not stated | SEC |